Evidence map›Paper›PMID 32349666›Full record

ArticleBMC genomics2020

Genomic characterization of Lactobacillus fermentum DSM 20052.

Katelyn Brandt, Matthew A Nethery, Sarah O'Flaherty, Rodolphe Barrangou

Abstract readComparative Study
In one paragraph

Article in BMC genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Comparative genomics ofComputational and structural biotechnology journal · 2023
    Article
  12. Article
  13. Article
  14. Genomic diversity of genusMicrobial genomics · 2022
    Article
  15. Article
  16. Genome Characterization ofAntibiotics (Basel, Switzerland) · 2021
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katelyn BrandtFunctional Genomics Graduate Program, North Carolina State University, Raleigh, NC, 27695, USA.
Matthew A NetheryFunctional Genomics Graduate Program, North Carolina State University, Raleigh, NC, 27695, USA.
Sarah O'FlahertyDepartment of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, Raleigh, NC, 27695, USA.
Rodolphe BarrangouFunctional Genomics Graduate Program, North Carolina State University, Raleigh, NC, 27695, USA. rbarran@ncsu.edu.ORCID http://orcid.org/0000-0002-0648-3504

Funding

College of Agriculture and Life Sciences, North Carolina State University Internal fundsDuPont Probiotics researchNorth Carolina Ag Foundation Probiotics research
6 · The paper itself

Abstract

backgroundLactobacillus fermentum, a member of the lactic acid bacteria complex, has recently garnered increased attention due to documented antagonistic properties and interest in assessing the probiotic potential of select strains that may provide human health benefits. Here, we genomically characterize L. fermentum using the type strain DSM 20052 as a canonical representative of this species.

resultsWe determined the polished whole genome sequence of this type strain and compared it to 37 available genome sequences within this species. Results reveal genetic diversity across nine clades, with variable content encompassing mobile genetic elements, CRISPR-Cas immune systems and genomic islands, as well as numerous genome rearrangements. Interestingly, we determined a high frequency of occurrence of diverse Type I, II, and III CRISPR-Cas systems in 72% of the genomes, with a high level of strain hypervariability.

conclusionsThese findings provide a basis for the genetic characterization of L. fermentum strains of scientific and commercial interest. Furthermore, our study enables genomic-informed selection of strains with specific traits for commercial product formulation, and establishes a framework for the functional characterization of features of interest.

Indexed as

Genome, BacterialCRISPR-Cas SystemsGenetic VariationGenomic IslandsGenomicsInterspersed Repetitive SequencesLimosilactobacillus fermentumPhylogenyComparative genomicsCRISPRFermentumLactobacillus

Identifiers

PMID32349666
PMCPMC7191730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.